PRLD

Prelude·NASDAQ

--(--)

Prelude (PRLD) Company Profile

Prelude Therapeutics Incorporated

A clinical-stage precision oncology company that developing innovative drug candidates for cancer

Industry

Biotechnology Ⅲ

Established Date

02/05/2016

Listing Date

09/25/2020

Exchange

NASDAQ Stock Exchange

Full-time Employees

Fiscal Year Ends

12-31

Website

www.preludetx.com

Security Type

Common stock

Office address

175 Innovation Boulevard, Wilmington, Delaware 19805

Business

Develops precision cancer medicines.

Introduction

Prelude Therapeutics Incorporated, founded in Delaware on February 5, 2016, is a clinical-stage precision oncology company dedicated to discovering and developing small molecule therapies optimized for key driving mechanisms of highly unmet cancer needs.